Wegovy Cash Price: What to Pay Without Insurance

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Brand-name Wegovy (semaglutide injection) typically costs between $1,350 and $1,500 per month when paying out-of-pocket, placing it beyond reach for many patients seeking GLP-1 therapy. Compounded semaglutide and tirzepatide from licensed 503A pharmacies offer clinically comparable options at a fraction of that price, with PlexusDx delivering personalized treatment plans without insurance requirements, membership fees, or hidden costs.

Why Wegovy Cash Price Is So High

Brand-name pharmaceutical pricing reflects years of research, FDA approval processes, and marketing expenses built into the final cost. Wegovy's manufacturer sets wholesale prices that insurance companies negotiate down; patients without coverage pay the full retail rate. This model makes name-brand GLP-1 therapy unaffordable for the 45 million American adults seeking weight loss treatment.

Compounding pharmacies operate under different regulatory pathways (503A licensure), allowing them to produce chemically identical semaglutide and tirzepatide at lower costs. The medications contain the same active ingredients, follow USP (United States Pharmacopeia) standards, and are prepared by licensed pharmacists—removing manufacturer markups while maintaining safety and efficacy.

Compounded Semaglutide vs. Wegovy: Cost Breakdown

PlexusDx compounded semaglutide injection is $189/mo month-to-month, or from $149/mo on the 6-month plan, representing an 89% savings compared to brand-name Wegovy's $1,350 starting price. Patients receive the same GLP-1 receptor agonist mechanism—appetite suppression and improved glycemic control—without paying for brand licensing or mass-market advertising. Your dose may need to go up. Your price won't.

Oral semaglutide through PlexusDx is $289/mo month-to-month (or $249/mo on the 6-month plan), offering flexibility for patients preferring tablets over injections. Both delivery methods come from licensed 503A compounding pharmacies across all 50 states, with HSA and FSA eligibility built in. There are no insurance requirements, no membership fees, and no restrictive enrollment contracts.

Tirzepatide as an Alternative to Wegovy

Tirzepatide (the active ingredient in Zepbound and Mounjaro) targets both GLP-1 and GIP receptors, potentially offering superior weight loss outcomes compared to semaglutide alone in clinical studies. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), while oral tirzepatide is $349/mo month-to-month, or from $279/mo on the 6-month plan—still substantially below brand-name pricing. Patients gain access to a dual-mechanism peptide without waiting lists or insurance denials.

For those seeking maximum efficacy, PlexusDx offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide, at $289/mo month-to-month, or from $249/mo on the 6-month plan. This approach allows clinicians to personalize therapy based on individual metabolic pathways and genetic predispositions, maximizing weight loss and metabolic health outcomes without proportional price increases.

Microdose GLP-1 Protocol: Affordable Entry Point

PlexusDx Microdose GLP-1 Protocol delivers a fixed-price $129-monthly option designed for patients starting GLP-1 therapy or seeking gentler dose escalation. Microdosing protocols use lower initial concentrations to minimize gastrointestinal side effects while establishing baseline tolerance. This tier-independent flat pricing removes the psychological barrier that prevents many patients from beginning treatment.

The Microdose Protocol suits patients new to GLP-1 compounds, those with medication sensitivity, or individuals managing multiple comorbidities requiring conservative dosing. As tolerance improves and clinical goals progress, patients can transition to full-dose semaglutide, tirzepatide, or dual-compound protocols without price shock—reinforcing PlexusDx's foundational promise that your dose may escalate, but your price remains fixed.

Personalization Through Genetic Testing

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predispositions transforms cost-benefit analysis: personalized therapy reduces trial-and-error medication switching, minimizes wasted doses, and accelerates time to clinical goal. PlexusDx integrates genetic insights into treatment planning, ensuring that lower monthly costs translate to faster, more reliable weight loss outcomes.

How to Access Affordable GLP-1 Without Insurance

PlexusDx enrollment requires no insurance verification, no membership fee, and no annual commitment. Patients complete an online health assessment, connect with a licensed clinician, and receive compounded medications shipped directly to their home. The entire process operates transparently: pricing is fixed per compound, HSA/FSA accounts cover costs, and no hidden surcharges apply regardless of dose adjustments.

All medications originate from licensed 503A compounding pharmacies operating under state pharmacy board oversight and USP standards. PlexusDx serves all 50 states, meaning geographic location does not affect access or pricing. Patients can start with the Microdose Protocol at $129 monthly, transition to standard-dose semaglutide at $189 monthly, or explore tirzepatide and dual-compound options—always knowing exactly what they will pay.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much cheaper is PlexusDx compounded semaglutide than Wegovy?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) versus Wegovy's $1,350+ retail price—an 89% cost reduction. Both contain identical semaglutide active ingredient and work through the same GLP-1 receptor mechanism. PlexusDx pricing remains flat regardless of dose escalation, eliminating surprise costs as your treatment progresses.

Is compounded semaglutide from PlexusDx as safe and effective as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient, prepared under USP standards and state pharmacy board oversight. Clinical efficacy and safety profiles are equivalent; differences reflect manufacturing source, not chemical composition. PlexusDx compounds are prepared by licensed pharmacists using pharmaceutical-grade materials.

Can I use HSA or FSA to pay for PlexusDx GLP-1 therapy?

Yes. All PlexusDx medications—including compounded semaglutide, tirzepatide, and the Microdose GLP-1 Protocol—are HSA and FSA eligible. This allows patients to use pre-tax dollars, further reducing out-of-pocket expenses. Combined with flat monthly pricing starting at $129, HSA/FSA eligibility makes personalized GLP-1 therapy genuinely affordable for most patients.

What are common GLP-1 side effects, and does the Microdose Protocol reduce them?

GLP-1 side effects—nausea, vomiting, constipation, and appetite loss—typically emerge during initial dose escalation and diminish as tolerance builds. The Microdose GLP-1 Protocol uses lower starting concentrations, allowing gradual adaptation and minimizing gastrointestinal disruption. Many patients transition to full-dose compounds after establishing baseline tolerance without experiencing severe nausea.

How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Price Without Insurance
• Wegovy Without Insurance
• Mounjaro Price Without Insurance
• Ozempic Price Without Insurance

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.